Corporate governance

ContextVision AB is registered in Sweden and is controlled by its Articles of Association according to the Companies Act in Sweden and Swedish law.

Since 1997, the company is listed on the Oslo Stock Exchange under the ticker CONTX and operates under Oslo Stock Exchange rules and regulations. ContextVision complies with all applicable guidelines and procedures stipulated in the Norwegian Code of Practice for Corporate Governance. The deviations are explained in the Corporate Governance report in the Annual Report.
ContextVision AB is registered in Sweden and is controlled by its Articles of Association according to the Companies Act in Sweden and Swedish law.

Since 1997, the company is listed on the Oslo Stock Exchange under the ticker CONTX and operates under Oslo Stock Exchange rules and regulations. ContextVision complies with all applicable guidelines and procedures stipulated in the Norwegian Code of Practice for Corporate Governance. The deviations are explained in the Corporate Governance report in the Annual Report.

Olof Sandén

Chairman

Olof (born 1962) works as Partner at TRANSEARCH, an international search. Olof has many years of experience from medical device companies in different leadership roles but also from other industries.
After studying at Chalmers, Gothenburg and ETH, Zurich, Olof worked at the Boston Consulting Group, first in Munich and later in the Stockholm office. Olof lived many years in Germany and worked as the Swedish Trade Commissionaire to Germany / Regional Manager Europe at Business Sweden. After that Olof held several senior positions at Elekta, including the role as Executive Vice President. Olof has also been CEO of RISE, Research Institutes of Sweden, with focus on merging the Swedish research institutes into one national organisation. Olof has carried out several M&A projects with subsequent integration work.
Olof’s board experiences are from different industries, including research-institutes, medical technology, e-commerce, sports equipment / sports facilities, both for private, listed and PE-owned companies. Today Olof’s serves on the board of two medical device companies Micropos and Scandidos, as well as a PE owned company Unisport OY.
Olof holds a master's degree from Chalmers / ETH Zurich and an Executive MBA from Columbia, New York.

He is a member of the Board since 2021

As of July 6, 2021, Sandén holds 3,000 shares in the company.
Martin Hedlund

Martin Hedlund

Hedlund (born 1952) is one of the founders of ContextVision AB. He holds a Master in Electrical Engineering Applied Physics at Linköping University. His PhD studies in image processing was interrupted when he founded the company, as a Research & Development Manager and later site manager in Linköping, leading a team to build one of the first advanced image analysis high-speed computers, namely the GOP-computer. Between 1999 and mid 2019 he worked as a CTO focusing on strategic product and business development. Since 2013 he introduced and worked with Artificial Intelligence/ Machine learning where he led his team to achieved top-scores in international competitions in Digital Pathology. He is an inventor of some patents within image processing and machine learning and has published several research papers.

He is a member of the Board since the company went public in 1997.

As of December 1, 2020, Hedlund owns 8,316,660 shares (10,7%) in ContextVision and he is also a board member of Cytacoat AB and the wholly owned Yakivu AB and DMGH Consulting.

Martin Ingvar

Ingvar (born 1955) has a background in cognitive neuroscience and is the Barbro and Bernard Osher Professor of Integrative Medicine at Karolinska Institutet, Stockholm Sweden. He has lead the MR Research Center for more than two decades. His present research interest is in formal description of clinical knowledge and quality in clinical care. He has devised new modes for semantic interoperability in information systems and laid a foundation for patient centric knowledge building in health care. He has published some 250 research papers and contributed to 15 books. His latest book is on knowledge and AI.

He is a member of the Board since 2020.

As of October 21, 2021, Ingvar holds 12,000 shares in the company.
Sven Günther-Hanssen

Sven Günther-Hanssen

Günther-Hanssen (born 1954) is one of the founders of ContextVision and he has previously served as CEO for the company, as well as chairman of the board and board member. He was re-elected to the board in 2011. Günther-Hanssen has acted as a venture capitalist and been involved in start-up companies in the medical, industrial and financial sectors in the capacity of investor as well as board member. He holds a M.Sc. degree in Industrial Engineering from the Institute of Technology at Linköping University.

As of December 1, 2020, Günther-Hanssen own 8,516,670 shares (11%) in the company.
Magne Jordanger

Magne Jordanger

Jordanger (born 1953) was first elected to the board in 2002. After a one year pause from the board during 2018, he was re-elected to the board again in May 2019. Jordanger holds a BA degree from IMD Lausanne, Switzerland 1981. Throughout his career as an owner-manager, Jordanger has operated various international industries and is presently the chairman or member of the following boards: Safe Information Group NV, NCL AB, Konsmo Fabrikker and OKK gruppen.

As of Dec 1, 2020, Jordanger controls 23,000,000 shares (29.73 %)
in ContextVision through the company Monsun AS.

Leadership Team

Gerald Pötzsch_CEO

Gerald Pötzsch

Chief Executive Officer 

Gerald Pötzsch joined ContextVision in August 2022 as CEO.
Gerald has many years of professional experience within Medical Technology, with various leadership roles across the globe.
After graduating from RWTH Aachen in Germany, Gerald completed two PhD programs in Engineering and Medicine and worked in management consulting. He then spent 16 years with Philips in commercially leading roles in Europe, as Senior Director for Innovation in the CTO office, and as business leader for a global solution business that he established in the US. He has worked within diagnostic and interventional imaging as well as informatics. Gerald’s focus has always been to bridge customer and supplier perspectives into joint business partnerships.
Gerald has board experience from privately owned and PE-owned companies as well as non-profit professional associations within the MedTech industry.

As of July 31st, 2022, Gerald holds 5,000 shares in the company.


Ann-Sofi Hoff

Chief Product Officer

Ann-Sofi Hoff joined ContextVision in March 2009 and holds the position as CPO since January 2022. She has previously held several different senior roles within the company, including Customer & Application Manager, Portfolio Manager and Marketing Manager. Her background covers more than 25 years of experience within product development and management, with a main focus on the MedTech industry, and positions at global companies such as Siemens Healthineers, ÅF (AFRY) and Ericsson. She has studied at the Faculty of Science at Stockholm University, and specialized with the Medical Physicist Master’s Program at the University of Gothenburg.

Markus Hökerberg

Interim Chief Financial Officer

Markus Hökerberg joined ContextVision as Interim CFO in Feb 2022. He has more than 20 years of experience from various financial positions in a broad range of industries. Markus’ expertise is within business development and financial management. He holds an officer exam from the Swedish Armed Forces, and a Bachelor of Science in Business Administration and Economics from Stockholm University.

Gunnar Läthén

Chief Technology Officer

Gunnar Läthén joined ContextVision in 2013 and became CTO in 2022. During his career within the company, he has worked actively in research and product development as a research scientist, and more recently as manager of R&D operations. His interests lie in the intersection between image processing, machine learning, software engineering, and driving operational excellence within the medical device field. He holds a PhD in visualization and media technology from Linköping University, and a double MSc in computational science and media technology and engineering.

Ola Lindblad

Chief Sales & Solution Officer

Ola Lindblad joined ContextVision in February 2020 as Vice President of Medical Imaging, became the interim CEO in Feb 2022 and now holds the position as Chief Sales and Solution Officer since Aug 2022. He has over 20 years' experience from the global software industry, working for companies such as IBM, PricewaterhouseCoopers and Boeing. His main focus has been on managing international sales and consulting teams, as well as business development in existing and new regions. Lindblad has a bachelor’s degree from Gothenburg School of Economics and Commercial Law.

Katarina Flood

Chief Service Officer

Flood joined ContextVision already in 2003, and holds the position as CSO since 2022. She has sixteen years’ experience as an Application Engineer developing and customizing the company’s products worldwide, including several years of expat positions in the U.S.A. and P.R. China. Since 2019 she manages the Application Services team. Katarina holds a M.Sc. in Applied Physics and Electrical Engineering, and a Licentiate of Engineering in Computer Vision from Linköping University.

Management

Fredrik Palm

Fredrik Palm

Chief Executive Officer

Palm joined ContextVision in January 2012 and became CEO April 2019. Palm has 20 years of experience within international life science business. After many years at Waters Corporation, he moved on to several sales and marketing positions at medical device companies, focusing on international expansion. His experience covers international sales, marketing and business development as well as concepts for value based communication. Palm has complemented his engineer background with studies in business management and strategic marketing.

As of October 22, 2021, Palm holds 30,700 shares in the company.
Arto Järvinen

Chief Technical Officer

Järvinen joined ContextVision in 2011, for the second time. He first joined the company in 1984, shortly after it was founded, having just majored in image processing at the Linköping and Stanford universities. Three years later, he left to work for the Swedish Attaché of Science and Technology in San Francisco. Since then, his career has included various management and consulting positions, such as management consultant at a global management consultancy, chief quality officer for a global PACS company and managing director for a medical device company. Järvinen’s expertise includes machine learning, image processing, system development, operational excellence, medical device regulations and management of high-tech companies in general.
Ann-Charlotte Linderoth

Ann-Charlotte Linderoth

Chief Financial Officer

Linderoth is Chief Financial Officer (CFO) at ContextVision since 2015. She joined the company already in 2011, starting as Financial Officer. Linderoth has more than 25 years of experience from various financial positions, mostly from companies within the field of medical devices. She holds a Bachelor of Science in Business Administration and Economics from the University of Stockholm.
Eskil Larsson

Eskil Larsson

Director of Special Projects

Larsson, Director of Special projects, joined ContextVision in 2011. Larsson has 36 years of industrial experience, mainly from the medical field. He has been R&D Manager and Marketing Manager at Siemens-Elema AB as well as CEO at AF Industrial Technology and Novator AB. At Siemens-Elema he handled the transfer of Mammography from Germany to Sweden and the development of the new Mammography system. Larsson has an M.Sc. in Electrical Engineering and has taken several management courses.

Magnus Aurell

VP Business Unit Digital Pathology

Magnus Aurell joined ContextVision in May 2020 as VP of Digital Pathology. Aurell has over 25 years of experience from the medtech and pharma industry, with a main focus on international commercialization. This includes business development, through new product development as well as through commercial expansions in existing and new geographical regions. Previously, Aurell was Business Unit Manager at another advanced imaging analysis company, AMRA Medical; before that he was CEO of EXINI Diagnostics, where he was responsible for the sale and integration of the company into Progenics Pharmaceutical, who acquired EXINI for their unique imaging biomarker within prostate cancer application. Magnus holds a Master of Science degree in Biophysics from Uppsala University.

Johanna Karling

Director of Regulatory Affairs & QA

Karling is Director of Regulatory Affairs and QA at ContextVision since January 2018. Karling has more than 25 years of experience within pharmaceutical and medical device business. She has held positions as head of QA and Regulatory Affairs in Medical Device companies, Aerocrine AB for 11 years and Bactiguard AB for 3 years. Between 2013 and 2018 she was a freelance consultant for Medical device companies providing expertise within QA, Regulatory Affairs and organizational development.
Her experience includes building up scalable Quality Management Systems for small businesses, and international regulatory affairs covering Europe, USA, Latin America and Asia, for various medical device and IVD device products.
She is representing ContextVision in The Alliance for Digital Pathology and its Reimbursement workgroup. The aim for this group is to establish standardization and guidelines for regulation of digital pathology products, and suitable reimbursement coding in the US.
She holds a Master of Science Degree in Chemical Engineering from the Royal Institute of Technology in Stockholm, Sweden.

Ola Lindblad

VP Medical Imaging

Ola Lindblad joined ContextVision in February 2020 as Vice President of Medical Imaging. He has over 20 years' experience from the global software industry, working for companies such as IBM, PricewaterhouseCoopers and Boeing. His main focus has been on managing international sales and consulting teams, as well as business development in existing and new regions. Lindblad has a bachelor’s degree from Gothenburg School of Economics and Commercial Law.

Auditors

External auditors are elected at the Annual General Meeting for a period of one year. At the Annual General Meeting 2019, Ernst & Young were reelected as auditor for the coming year, with Andreas Troberg as acting auditor.

Downloads

Corporate Governance (pdf)
Articles of Association (pdf)
Available in Swedish only

Investors contact

For investors information and/or inquiries, please contact
Ola Lindblad, Interim Chief Executive Officer

Investors contact

For investors information and/or inquiries, please contact
Gerald Pötzsch, Chief Executive Officer